Summaries & Associations of Study Results
TR-328 Methyl Carbamate
Target Organs and Levels of Evidence
NTP Technical Report Number 328
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| METHYL CARBAMATE 598-55-0 |
08/19/86 | CHEMICAL INTERMEDIATE FOR FABRIC FINISH RESINS. (TDB) | Gavage R: 0,100,200, M: 0,500,1000 MG/KG/50 PER GROUP | Microbiological Associates |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: CLEAR EVIDENCE | LIVER: NEOPLASTIC NODULE 3/50 0/50 3/49; CARCINOMA 1/50 0/50 4/49 | |||
| NON-NEOPLASTIC LESIONS: | HARDERIAN GLAND: INFLAMMATION 4/50 11/50 16/50 | |||
| FR: CLEAR EVIDENCE | LIVER: NEOPLASTIC NODULE 0/50 0/50 5/49; CARCINOMA 0/50 0/50 1/50 | |||
| NON-NEOPLASTIC LESIONS: | HARDERIAN GLAND: INFLAMMATION 7/50 16/50 30/50 | |||
| MM: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | LUNG: HYPERPLASIA, ADENOMATOUS 13/50 19/50 24/49; HISTIOCYTOSIS 11/50 7/50 21/49 | |||
| FM: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | LUNG: HYPERPLASIA, ADENOMATOUS 7/49 10/50 18/50; HISTIOCYTOSIS 9/49 10/50 21/50 | |||
Web page last updated on February 10, 2006
